These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10351166)

  • 1. Evaluation of sampling procedures for quality monitoring of red cell concentrates: the need for improving sampling and sample handling techniques of red cell concentrate.
    Seghatchian MJ; Krailadsiri P; Sutherland J; Vasconcelos E; de Sousa G
    Transfus Sci; 1998 Dec; 19(4):393-8. PubMed ID: 10351166
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality assurance and standards for red cells and platelets.
    Sweeney J
    Vox Sang; 1998; 74 Suppl 2():201-5. PubMed ID: 9704446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International views on universal leucodepletion: the perspective in The Netherlands.
    de Wit HC
    Transfus Sci; 1998 Dec; 19(4):353-4. PubMed ID: 10351153
    [No Abstract]   [Full Text] [Related]  

  • 4. Is leukoreduction of blood components for everyone?
    Corwin HL; AuBuchon JP
    JAMA; 2003 Apr; 289(15):1993-5. PubMed ID: 12697804
    [No Abstract]   [Full Text] [Related]  

  • 5. National French observatory of the quality of blood components for transfusion.
    Chabanel A; Masse M; Begue S;
    Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national quality assessment scheme for counting residual leucocytes in unfixed leucodepleted products: the effect of standardisation and 48 hour storage.
    Krailadsiri P; Seghatchian J; Rigsby P; Bukasa A; Bashir S
    Transfus Apher Sci; 2002 Feb; 26(1):73-81. PubMed ID: 11931380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in QA of leucodepleted blood component and current standard(s). Challenges in quality assurance of leukoreduced components.
    Dumont LJ
    Transfus Sci; 1998 Dec; 19(4):377-80. PubMed ID: 10351162
    [No Abstract]   [Full Text] [Related]  

  • 8. French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).
    Chamfly V
    Transfus Sci; 1998 Dec; 19(4):333-42. PubMed ID: 10351148
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of transfusion products in blood banking.
    Franchini M; Capuzzo E; Turdo R; Glingani C
    Semin Thromb Hemost; 2014 Mar; 40(2):227-31. PubMed ID: 24474089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood bag temperature monitoring system.
    Aalaei S; Amini S; Keramati MR; Shahraki H; Abu-Hanna A; Eslami S
    Stud Health Technol Inform; 2014; 205():730-4. PubMed ID: 25160283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International views on universal leucodepletion: the perspective in NBS, England.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150
    [No Abstract]   [Full Text] [Related]  

  • 12. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International views on universal leucodepletion: the perspective in Germany.
    Seitz MD
    Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concentrated red blood cells transfusion in Yaoundé, Cameroon: what quality?].
    Mbanya D; Nouthe B; Tayou Tagny C; Moudourou S; Ngogang J
    Transfus Clin Biol; 2007 Nov; 14(5):453-6. PubMed ID: 18295526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operational and research approaches to universal leucodepletion in Scotland.
    Prowse C
    Transfus Sci; 1998 Dec; 19(4):367-9. PubMed ID: 10351158
    [No Abstract]   [Full Text] [Related]  

  • 16. NBS approaches to the approval of suppliers of leucodepletion systems.
    Smith KJ
    Transfus Sci; 1998 Dec; 19(4):371-2. PubMed ID: 10351159
    [No Abstract]   [Full Text] [Related]  

  • 17. [The importance of quality of whole blood and erythrocyte concentrates for autologous transfusion. A literature survey and meta-analysis of in vivo erythrocyte recovery].
    Karger R; Kretschmer V
    Anaesthesist; 1996 Aug; 45(8):694-707. PubMed ID: 8967582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions.
    Hébert PC; Fergusson D; Blajchman MA; Wells GA; Kmetic A; Coyle D; Heddle N; Germain M; Goldman M; Toye B; Schweitzer I; vanWalraven C; Devine D; Sher GD;
    JAMA; 2003 Apr; 289(15):1941-9. PubMed ID: 12697796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International views on universal leucodepletion: the perspective in NBS, Ireland.
    Murphy W
    Transfus Sci; 1998 Dec; 19(4):349-50. PubMed ID: 10351151
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quality assurance in blood transfusion: the advantages and limitations].
    Hergon E
    Transfus Clin Biol; 1998 Apr; 5 Suppl 1():36S-41S. PubMed ID: 9622844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.